Bristol Myers Squibb joins in on challenging Medicare drug price negotiation program
U.S. pharmaceutical company Bristol Myers Squibb (BMS) on Friday became the latest organization to file a legal challenge against the the Medicare drug price negotiation program established by the Inflation Reduction Act (IRA). This suit echoes the complaints filed by Merck & Co. and the Chamber…
#bristolmyerssquibb #bms #medicare #merckco #chamberofcommerce #fifthamendments #ira #firstamendment #medicaid #karinejeanpierre